Ulcerative Colitis
- Danese, Silvio M.D.
- Fiocchi, Claudio M.D.
From the Department of Gastroenterology, Istituto Clinico Humanitas, Milan (S.D.); and the Department of Gastroenterology and Hepatology, Digestive Disease Institute, and Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland (C.F.).
Address reprint requests to Dr. Fiocchi at the Cleveland Clinic Foundation, Lerner Research Institute, Department of Pathobiology/NC22, 9500 Euclid Ave., Cleveland, OH 44195.
Dr. Danese reports receiving fees for board membership from Merck Sharp & Dohme, consulting fees from Schering Plough, AstraZeneca, Abbott Laboratories, and Takeda Millennium, and lecture fees, including fees for service on speakers' bureaus, from UCB Pharma, Ferring, and Merck Sharp & Dohme; and Dr. Fiocchi, receiving lecture fees, including fees for service on speakers' bureaus, from Merck Sharp & Dohme and Broad Medical Research Program.
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
No other potential conflict of interest relevant to this article was reported.
We thank Jean-Paul Achkar, Mary Bronner, Jeffry Katz, Helmut Neumann, Markus Neurath, Julian Panes, Asit Parikh, Laurent Peyrin-Biroulet, Bo Shen, Michael Sivak, Warren Strober, Scott Strong, Gert van Assche, and Severine Vermeire for providing comments on the figures and expert suggestions.
